Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422135 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females
A Phase 1 study, sponsored by Agile Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01422135 is a Phase 1 study that has completed, run by Agile Therapeutics. The registered enrollment target is 24 participants.
The verdict
NCT01422135, a Phase 1 study, has completed, sponsored by Agile Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a pharmacokinetics and safety study over 3 weekly applications.
Interventions
- DRUG AG200-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422135
The ClinicalTrials.gov registry entry for NCT01422135 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agile Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AG200-15 is the first listed.
NCT01422135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01422135 about?
NCT01422135 is a clinical study titled "Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females". This is a pharmacokinetics and safety study over 3 weekly applications.
What is the current status of trial NCT01422135?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2011-02. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01422135?
The interventions under investigation include: AG200-15 (DRUG).
Who is sponsoring clinical trial NCT01422135?
This trial is sponsored by Agile Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.